Literature DB >> 10993447

Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.

E Shibosawa1, K Tsutsumi, T Takakuwa, S Takahashi.   

Abstract

BACKGROUND: Matrix metalloprotease-9 (MMP-9) plays an important role in the degradation of extracellular matrix (ECM). In cholesteatoma there are significant changes in the composition of the ECM, supporting the view of a disturbed cell-ECM interaction. It has been reported that in cholesteatoma tissues, MMP-9 is expressed in epithelial cells but not in stromal cells. In this study, we report conflicting results regarding the identity of the cholesteatoma cells that express MMP-9.
METHODS: An immunohistochemical assay was performed to examine the expression of MMP-9 in 25 cases (formalin-fixed paraffin-embedded sections) of cholesteatoma, using an MMP-9-specific monoclonal antibody.
RESULTS: In all cholesteatomas examined, MMP-9 was expressed in the stromal cells but not in the epithelial cells. MMP-9 immunostaining was undetectable in external auditory meatal skin (n = 5) and tympanic membrane (n = 3).
CONCLUSIONS: These results suggest that the MMP-9 expressed in stromal cells may be involved in the disturbed cell-ECM interaction associated with the process of cholesteatoma formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993447

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

1.  Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect.

Authors:  Kristaps Dambergs; Gunta Sumeraga; Māra Pilmane
Journal:  Iran J Otorhinolaryngol       Date:  2022-03

2.  Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion.

Authors:  Salvatore Raffa; Laura Leone; Cristina Scrofani; Simonetta Monini; Maria Rosaria Torrisi; Maurizio Barbara
Journal:  Histochem Cell Biol       Date:  2012-04-06       Impact factor: 4.304

3.  Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro.

Authors:  Hitome Kobayashi; Kazuhito Asano; Ken-ichi Kanai; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

4.  The evaluation of oxidative stress in the serum and tissue specimens of patients with chronic otitis media.

Authors:  Mehmet Fatih Garça; Mahfuz Turan; Barış Avşar; Ferhat Kalkan; Halit Demir; Ahmet Kozan; Nazım Bozan
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

Review 5.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

6.  Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.

Authors:  Carlos Eduardo Borges Rezende; Ricardo Peres do Souto; Priscila Bogar Rapoport; Laís de Campos; Marcela Bovo Generato
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.